1. Population pharmacokinetic modelling and simulation of fremanezumab in healthy subjects and patients with migraine. Issue 12 (9th December 2019) Authors: Fiedler‐Kelly, Jill B.; Cohen‐Barak, Orit; Morris, Denise N.; Ludwig, Elizabeth; Rasamoelisolo, Michele; Shen, Honglue; Levi, Micha Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 12(2019) Page Start: 2721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy. (28th October 2016) Authors: Xu, Xiaoying; Khadzhynov, Dmytro; Peters, Harm; Chaves, Ricardo L.; Hamed, Kamal; Levi, Micha; Corti, Natascia Journal: British journal of clinical pharmacology Issue: Volume 83:Number 3(2017:Mar.) Page Start: 498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach. (September 2021) Authors: Cohen-Barak, Orit; Radivojevic, Andrijana; Jones, Aksana; Fiedler-Kelly, Jill; Gillespie, Michael; Brennan, Michael; Gutman, Dikla; Rasamoelisolo, Michele; Hallak, Hussein; Loupe, Pippa; Kessler, Yoel; Ning, Xiaoping; Levi, Micha; Ahn, Andrew H; Rabinovich-Guilatt, Laura Journal: Cephalalgia Issue: Volume 41:Number 10(2021) Page Start: 1065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone. Issue 7 (4th March 2022) Authors: Perlstein, Itay; Merenlender Wagner, Avia; Gomeni, Roberto; Lamson, Michael; Harary, Eran; Spiegelstein, Ofer; Kalmanczhelyi, Attila; Tiver, Ryan; Loupe, Pippa; Levi, Micha; Elgart, Anna Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 7(2022) Page Start: 865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 127 Cardiovascular Safety Assessment of Deutetrabenazine in Healthy Volunteers and Implications for Patients With Huntington Disease or Tardive Dyskinesia. (15th June 2018) Authors: Cox, Donna S.; Levi, Micha; Rabinovich-Guilatt, Laura; Truong, David; Stamler, David Journal: CNS spectrums Issue: Volume 23:Number 1(2018:Feb.) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses. Issue 7 (23rd May 2020) Authors: Fiedler‐Kelly, Jill; Passarell, Julie; Ludwig, Elizabeth; Levi, Micha; Cohen‐Barak, Orit Journal: Headache Issue: Volume 60:Issue 7(2020) Page Start: 1376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects. (9th August 2018) Authors: Schneider, Frank; Erisson, Lavi; Beygi, Hooman; Bradbury, Margaret; Cohen‐Barak, Orit; Grachev, Igor D.; Guzy, Serge; Loupe, Pippa S.; Levi, Micha; McDonald, Mirna; Savola, Juha‐Matti; Papapetropoulos, Spyros; Tracewell, William G.; Velinova, Maria; Spiegelstein, Ofer Journal: British journal of clinical pharmacology Issue: Volume 84:Number 10(2018) Page Start: 2422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Modeling viral kinetics and treatment outcome during alisporivir interferon‐free treatment in hepatitis C virus genotype 2 and 3 patients. Issue 5 (1st April 2014) Authors: Guedj, Jeremie; Yu, Jing; Levi, Micha; Li, Bin; Kern, Steven; Naoumov, Nikolai V.; Perelson, Alan S. Journal: Hepatology Issue: Volume 59:Issue 5(2014:May) Page Start: 1706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis. (22nd February 2013) Authors: Levi, Micha; Grange, Susan; Frey, Nicolas Journal: Journal of clinical pharmacology Issue: Volume 53:Number 2(2013:Feb.) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗